Our results show that apyrase (1 U/mL) significantly negated PR-induced upregulation of Slug and CDD in cancer cells (Figure 5A,B) but apyrase did not significantly modulate hENT1 expression level (Supplementary Figure S3). Here, SLC29A1 is linked to cancer.